Masimo | MASI - Marktkapitalisierung

Aktienkurs
178.63
Täglich Wechseln
-0.08 -0.04%
Monatlich
0.30%
Jährlich
9.09%
Q2 Prognose
174.81




Marktkapitalisierung Veränderung Datum
Abbott USD 168.02B 10.39B 2026-04
Align Technology USD 11.2B 2.13B 2025-12
AngioDynamics USD 511M 94M 2025-09
Artivion USD 2.18B 176M 2025-12
AtriCure USD 1.97B 215M 2025-12
Avanos Medical USD 521M 15M 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Boston Scientific USD 95.61B 2.35B 2026-04
Dexcom USD 25.88B 503M 2025-12
Edwards Lifesciences USD 47.05B 884M 2026-04
General Electric Aerospace USD 310.34B 13.85B 2026-04
Globus Medical USD 11.69B 3.95B 2025-12
Haemonetics USD 3.76B 1.44B 2025-12
Insulet USD 20B 1.74B 2025-12
Integra LifeSciences USD 967M 150M 2025-12
Intuitive Surgical USD 159.96B 3.77B 2026-04
Masimo USD 6.84B 839M 2025-12
Orthofix International USD 604M 25M 2025-12
Owens Minor USD 217M 154M 2025-12
ResMed USD 35.16B 4.79B 2025-12
Steris USD 24.88B 511M 2025-12
Stryker USD 134.41B 6.92B 2025-12
Tandem Diabetes Care USD 1.49B 670M 2025-12
Teleflex USD 5.39B 91M 2025-12
Thermo Fisher Scientific USD 177.96B 4.7B 2026-04
Zimmer Biomet Holdings USD 17.82B 1.69B 2025-12